Clinical trial NCT05489068: Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
Official title: Adapting Intake Procedures to Improve Treatment Delivery in Addiction Treatment
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Substance-Related Disorders
Treatment Adherence
Lead sponsor: University of New Mexico
Sponsor class: OTHER
Collaborators: name: National Institute on Drug Abuse (NIDA)
First posted: 2022-08-05
Enrollment: 150
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Effectiveness-Implementation Hybrid Type 1 Design
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.


Eligibility criteria: Inclusion Criteria (client participants):

* English-speaking adults seeking treatment for alcohol or other drug use at one of two outpatient addiction treatment programs
* Provision of signed and dated informed consent form
* Stated willingness to comply with all study procedures
* Physically withdrawn from alcohol or other drugs

Inclusion Criteria (personnel participants):

* English-speaking adults currently employed at one of the two outpatient addiction treatment programs
* Provision of electronic informed consent

Exclusion Criteria (client participants):

* Experiencing severe withdrawal symptoms
* Actively psychotic, manic, and/or suicidal

Exclusion Criteria (personnel participants):

* current position: facility owner or clinical director

Primary outcomes:
measure: Number of participants who attended the first outpatient treatment program session based on electronic medical record review
timeFrame: up to 36 weeks
measure: Number of treatment sessions attended during the three-month outpatient treatment program based on electronic medical record review
timeFrame: up to 36 weeks
measure: Number of participants who completed the three-month outpatient treatment program based on electronic medical record review
timeFrame: up to 36 weeks
Secondary outcomes:
measure: Change from baseline in client readiness to enter treatment on the University of Rhode Island Change Assessment Scale (URICA) at 1 hour post-intake
timeFrame: baseline and 1 hour post-intake
measure: Score on therapeutic alliance on the Working Alliance Inventory (WAI) at 1-hour post-intake
timeFrame: 1 hour post-intake
Other outcomes:
measure: Change from baseline in organizational readiness to change on the Texas Christian University-Organizational Readiness to Change (TCU-ORC) at 1 year
timeFrame: baseline and 1 year
measure: Change from baseline in organizational readiness to change on the Readiness for Organizational Change (ROC) at 1 year
timeFrame: baseline and 1 year
measure: Change from baseline in organizational capability to change on the Change Process Capability Questionnaire (CPCQ) at Year 1
timeFrame: baseline and 1 year
Locations:
city: Albuquerque
country: United States
facility: Turning Point Recovery Center
state: New Mexico
Study officials:
affiliation: University of New Mexico
name: Margo Hurlocker, PhD
role: PRINCIPAL_INVESTIGATOR
References: